Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09
Tarlaci S – Venlafaxine and escitalopram are both effective in the prophylaxis of migraine headache without depression and anxiety. This effect was independent of mood disorder. Escitalopram should be the first choice because of its fewer side effects, but venlafaxine may be used if escitalopram is found to be insufficient.
Related Articles
Review: differences in efficacy and acceptability exist for 12 new-generation antidepressants for major depression
Evidence-Based Medicine, 10/26/09
Relevance Score: 79%
Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09
Relevance Score: 69%
CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine
Expert Review of Neurotherapeutics, 11/12/09
Relevance Score: 68%
Controversies in migraine
Nurse Prescribing, 10/09/09
Relevance Score: 68%
New drugs for migraine
The Journal of Headache and Pain, 10/05/09
Relevance Score: 68%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/20/09
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis
Journal of Rheumatology, 11/20/09
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
A cluster of amyotrophic lateral sclerosis in New Hampshire: A possible role for toxic cyanobacteria blooms
Amyotrophic Lateral Sclerosis, 11/20/09
Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis
Multiple Sclerosis, 11/20/09
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
British Journal of Cancer, 11/20/09
Today in Preventive Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Relationships of BMI to Cardiovascular Risk Factors Differ by Ethnicity
Obesity, 11/20/09
Use of Oral N-Acetylcysteine for Protection of Melanocytic Nevi against UV-Induced Oxidative Stress: Towards a Novel Paradigm for Melanoma Chemoprevention
Clinical Cancer Research, 11/20/09
A mild favorable effect of soy protein with isoflavones on body composition - a 6-month double-blind randomized placebo-controlled trial among Chinese postmenopausal women
International Journal of Obesity, 11/19/09
Today in Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
A Psychopathological Study of Substance-Induced Psychoses in a Sample of Spanish Patients
European Addiction Research, 11/20/09
Early- and Delayed Antipsychotic Response and Prediction of Outcome in 528 Severely Impaired Patients with Schizophrenia Treated with Amisulpride
Pharmacopsychiatry, 11/20/09
Attentional Bias for Threat in Older Adults: Moderation of the Positivity Bias by Trait Anxiety and Stimulus Modality
Psychology and Aging, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


